BerGenBio works continuously to ensure financial flexibility in the short and long term to achieve its strategic and operational objectives. Capital markets are used as a source of liquidity when this is appropriate and when conditions in these markets are acceptable.
In addition, BerGenBio has historically applied for and received governmental grants. The Company expects to also in the future apply for grants as a source of funding.
BerGenBio does not use debt for financing. Consequently, BerGenBio does not have any covenants related to debt.